Compare ARTL & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARTL | TNON |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.8M |
| IPO Year | 2014 | 2021 |
| Metric | ARTL | TNON |
|---|---|---|
| Price | $3.45 | $3.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $44.38 |
| AVG Volume (30 Days) | 1.3M | ★ 9.9M |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,944,000.00 |
| Revenue This Year | N/A | $46.86 |
| Revenue Next Year | N/A | $63.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 20.35 |
| 52 Week Low | $0.52 | $0.13 |
| 52 Week High | $19.91 | $17.84 |
| Indicator | ARTL | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 50.09 |
| Support Level | $3.20 | $0.52 |
| Resistance Level | $6.81 | $7.15 |
| Average True Range (ATR) | 1.26 | 0.32 |
| MACD | -0.30 | -0.03 |
| Stochastic Oscillator | 0.16 | 42.42 |
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.